Synthesis of non-symmetric N-benzylbispidinol amides and study of their inhibitory activity against the main protease of the SARS-CoV-2 virus

Based on the data obtained by molecular modeling of the non-covalent interaction of non-symmetric N -benzylbispidin-9-ol amides with the active site of the main protease 3CLpro of the SARS-CoV-2 virus, a series of compounds was synthesized, and their inhibitory activity against 3CLpro was studied an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Russian chemical bulletin 2023, Vol.72 (1), p.239-247
Hauptverfasser: Dalinger, A. I., Baev, D. S., Yarovaya, O. I., Chirkova, V. Yu, Sharlaeva, E. A., Belenkaya, S. V., Shcherbakov, D. N., Salakhutdinov, N. F., Vatsadze, S. Z.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 247
container_issue 1
container_start_page 239
container_title Russian chemical bulletin
container_volume 72
creator Dalinger, A. I.
Baev, D. S.
Yarovaya, O. I.
Chirkova, V. Yu
Sharlaeva, E. A.
Belenkaya, S. V.
Shcherbakov, D. N.
Salakhutdinov, N. F.
Vatsadze, S. Z.
description Based on the data obtained by molecular modeling of the non-covalent interaction of non-symmetric N -benzylbispidin-9-ol amides with the active site of the main protease 3CLpro of the SARS-CoV-2 virus, a series of compounds was synthesized, and their inhibitory activity against 3CLpro was studied and compared with that of the known inhibitor ML188 (IC 50 = 1.56±0.55 µmol L −1 ). It was found that only compound 1g containing the 1,4-dihydroindeno[1,2- c ]pyrazole fragment showed moderate activity (IC 50 = 100±5.7µmol L −1 ) and was characterized by the highest calculated binding energy among the studied bispidine derivatives according to molecular docking data.
doi_str_mv 10.1007/s11172-023-3729-x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9926410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2779344746</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-fd9e0a7117cf133e27c8a37ad06566e64e269049aee36ed1c3d8c20f2b9661e23</originalsourceid><addsrcrecordid>eNp1kUuLFDEUhQtRnHH0B7iRgBs30TyqkspGGJrxAYOCrW5DOnWrO0NV0iapZsr_4H82RbfjA1zlwP3Oyb2cqnpKyUtKiHyVKKWSYcI45pIpfHuvOqeN5FhRSe8XTYTADWubs-pRSjeEENa27cPqjIuWyqZpz6sf69nnHSSXUOiRDx6neRwhR2fRB7wB_30eNi7tXed8GJAZXQcJGd-hlKduXkzF7iJyfuc2Loc4I2OzO7hcxNY4n_JCoLFItI8hg0lwsqH15ac1XoWvmKGDi1N6XD3ozZDgyem9qL68ufq8eoevP759v7q8xrYmJOO-U0CMLMfbnnIOTNrWcGk6IhohQNTAhCK1MgBcQEct71rLSM82SggKjF9Ur4-5-2kzQmfB52gGvY9uNHHWwTj998S7nd6Gg1aKiZqSEvDiFBDDtwlS1qNLFobBeAhT0kxKxeta1qKgz_9Bb8IUfTlvoYRolJB1oeiRsjGkFKG_W4YSvZStj2XrUrZeyta3xfPszyvuHL_aLQA7AqmM_Bbi76__n_oTIuS4WQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2776659674</pqid></control><display><type>article</type><title>Synthesis of non-symmetric N-benzylbispidinol amides and study of their inhibitory activity against the main protease of the SARS-CoV-2 virus</title><source>SpringerNature Journals</source><creator>Dalinger, A. I. ; Baev, D. S. ; Yarovaya, O. I. ; Chirkova, V. Yu ; Sharlaeva, E. A. ; Belenkaya, S. V. ; Shcherbakov, D. N. ; Salakhutdinov, N. F. ; Vatsadze, S. Z.</creator><creatorcontrib>Dalinger, A. I. ; Baev, D. S. ; Yarovaya, O. I. ; Chirkova, V. Yu ; Sharlaeva, E. A. ; Belenkaya, S. V. ; Shcherbakov, D. N. ; Salakhutdinov, N. F. ; Vatsadze, S. Z.</creatorcontrib><description>Based on the data obtained by molecular modeling of the non-covalent interaction of non-symmetric N -benzylbispidin-9-ol amides with the active site of the main protease 3CLpro of the SARS-CoV-2 virus, a series of compounds was synthesized, and their inhibitory activity against 3CLpro was studied and compared with that of the known inhibitor ML188 (IC 50 = 1.56±0.55 µmol L −1 ). It was found that only compound 1g containing the 1,4-dihydroindeno[1,2- c ]pyrazole fragment showed moderate activity (IC 50 = 100±5.7µmol L −1 ) and was characterized by the highest calculated binding energy among the studied bispidine derivatives according to molecular docking data.</description><identifier>ISSN: 1066-5285</identifier><identifier>EISSN: 1573-9171</identifier><identifier>DOI: 10.1007/s11172-023-3729-x</identifier><identifier>PMID: 36817558</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Amides ; Chemistry ; Chemistry and Materials Science ; Chemistry/Food Science ; Full ; Full Articles ; Inorganic Chemistry ; Molecular docking ; Organic Chemistry ; Protease ; Pyrazole ; Severe acute respiratory syndrome coronavirus 2 ; Viruses</subject><ispartof>Russian chemical bulletin, 2023, Vol.72 (1), p.239-247</ispartof><rights>Springer Science+Business Media LLC 2023</rights><rights>Springer Science+Business Media LLC 2023.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-fd9e0a7117cf133e27c8a37ad06566e64e269049aee36ed1c3d8c20f2b9661e23</citedby><cites>FETCH-LOGICAL-c400t-fd9e0a7117cf133e27c8a37ad06566e64e269049aee36ed1c3d8c20f2b9661e23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11172-023-3729-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11172-023-3729-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,315,781,785,886,4025,27928,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36817558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dalinger, A. I.</creatorcontrib><creatorcontrib>Baev, D. S.</creatorcontrib><creatorcontrib>Yarovaya, O. I.</creatorcontrib><creatorcontrib>Chirkova, V. Yu</creatorcontrib><creatorcontrib>Sharlaeva, E. A.</creatorcontrib><creatorcontrib>Belenkaya, S. V.</creatorcontrib><creatorcontrib>Shcherbakov, D. N.</creatorcontrib><creatorcontrib>Salakhutdinov, N. F.</creatorcontrib><creatorcontrib>Vatsadze, S. Z.</creatorcontrib><title>Synthesis of non-symmetric N-benzylbispidinol amides and study of their inhibitory activity against the main protease of the SARS-CoV-2 virus</title><title>Russian chemical bulletin</title><addtitle>Russ Chem Bull</addtitle><addtitle>Russ Chem Bull</addtitle><description>Based on the data obtained by molecular modeling of the non-covalent interaction of non-symmetric N -benzylbispidin-9-ol amides with the active site of the main protease 3CLpro of the SARS-CoV-2 virus, a series of compounds was synthesized, and their inhibitory activity against 3CLpro was studied and compared with that of the known inhibitor ML188 (IC 50 = 1.56±0.55 µmol L −1 ). It was found that only compound 1g containing the 1,4-dihydroindeno[1,2- c ]pyrazole fragment showed moderate activity (IC 50 = 100±5.7µmol L −1 ) and was characterized by the highest calculated binding energy among the studied bispidine derivatives according to molecular docking data.</description><subject>Amides</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>Chemistry/Food Science</subject><subject>Full</subject><subject>Full Articles</subject><subject>Inorganic Chemistry</subject><subject>Molecular docking</subject><subject>Organic Chemistry</subject><subject>Protease</subject><subject>Pyrazole</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Viruses</subject><issn>1066-5285</issn><issn>1573-9171</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp1kUuLFDEUhQtRnHH0B7iRgBs30TyqkspGGJrxAYOCrW5DOnWrO0NV0iapZsr_4H82RbfjA1zlwP3Oyb2cqnpKyUtKiHyVKKWSYcI45pIpfHuvOqeN5FhRSe8XTYTADWubs-pRSjeEENa27cPqjIuWyqZpz6sf69nnHSSXUOiRDx6neRwhR2fRB7wB_30eNi7tXed8GJAZXQcJGd-hlKduXkzF7iJyfuc2Loc4I2OzO7hcxNY4n_JCoLFItI8hg0lwsqH15ac1XoWvmKGDi1N6XD3ozZDgyem9qL68ufq8eoevP759v7q8xrYmJOO-U0CMLMfbnnIOTNrWcGk6IhohQNTAhCK1MgBcQEct71rLSM82SggKjF9Ur4-5-2kzQmfB52gGvY9uNHHWwTj998S7nd6Gg1aKiZqSEvDiFBDDtwlS1qNLFobBeAhT0kxKxeta1qKgz_9Bb8IUfTlvoYRolJB1oeiRsjGkFKG_W4YSvZStj2XrUrZeyta3xfPszyvuHL_aLQA7AqmM_Bbi76__n_oTIuS4WQ</recordid><startdate>2023</startdate><enddate>2023</enddate><creator>Dalinger, A. I.</creator><creator>Baev, D. S.</creator><creator>Yarovaya, O. I.</creator><creator>Chirkova, V. Yu</creator><creator>Sharlaeva, E. A.</creator><creator>Belenkaya, S. V.</creator><creator>Shcherbakov, D. N.</creator><creator>Salakhutdinov, N. F.</creator><creator>Vatsadze, S. Z.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2023</creationdate><title>Synthesis of non-symmetric N-benzylbispidinol amides and study of their inhibitory activity against the main protease of the SARS-CoV-2 virus</title><author>Dalinger, A. I. ; Baev, D. S. ; Yarovaya, O. I. ; Chirkova, V. Yu ; Sharlaeva, E. A. ; Belenkaya, S. V. ; Shcherbakov, D. N. ; Salakhutdinov, N. F. ; Vatsadze, S. Z.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-fd9e0a7117cf133e27c8a37ad06566e64e269049aee36ed1c3d8c20f2b9661e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Amides</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>Chemistry/Food Science</topic><topic>Full</topic><topic>Full Articles</topic><topic>Inorganic Chemistry</topic><topic>Molecular docking</topic><topic>Organic Chemistry</topic><topic>Protease</topic><topic>Pyrazole</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dalinger, A. I.</creatorcontrib><creatorcontrib>Baev, D. S.</creatorcontrib><creatorcontrib>Yarovaya, O. I.</creatorcontrib><creatorcontrib>Chirkova, V. Yu</creatorcontrib><creatorcontrib>Sharlaeva, E. A.</creatorcontrib><creatorcontrib>Belenkaya, S. V.</creatorcontrib><creatorcontrib>Shcherbakov, D. N.</creatorcontrib><creatorcontrib>Salakhutdinov, N. F.</creatorcontrib><creatorcontrib>Vatsadze, S. Z.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Russian chemical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dalinger, A. I.</au><au>Baev, D. S.</au><au>Yarovaya, O. I.</au><au>Chirkova, V. Yu</au><au>Sharlaeva, E. A.</au><au>Belenkaya, S. V.</au><au>Shcherbakov, D. N.</au><au>Salakhutdinov, N. F.</au><au>Vatsadze, S. Z.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of non-symmetric N-benzylbispidinol amides and study of their inhibitory activity against the main protease of the SARS-CoV-2 virus</atitle><jtitle>Russian chemical bulletin</jtitle><stitle>Russ Chem Bull</stitle><addtitle>Russ Chem Bull</addtitle><date>2023</date><risdate>2023</risdate><volume>72</volume><issue>1</issue><spage>239</spage><epage>247</epage><pages>239-247</pages><issn>1066-5285</issn><eissn>1573-9171</eissn><abstract>Based on the data obtained by molecular modeling of the non-covalent interaction of non-symmetric N -benzylbispidin-9-ol amides with the active site of the main protease 3CLpro of the SARS-CoV-2 virus, a series of compounds was synthesized, and their inhibitory activity against 3CLpro was studied and compared with that of the known inhibitor ML188 (IC 50 = 1.56±0.55 µmol L −1 ). It was found that only compound 1g containing the 1,4-dihydroindeno[1,2- c ]pyrazole fragment showed moderate activity (IC 50 = 100±5.7µmol L −1 ) and was characterized by the highest calculated binding energy among the studied bispidine derivatives according to molecular docking data.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>36817558</pmid><doi>10.1007/s11172-023-3729-x</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1066-5285
ispartof Russian chemical bulletin, 2023, Vol.72 (1), p.239-247
issn 1066-5285
1573-9171
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9926410
source SpringerNature Journals
subjects Amides
Chemistry
Chemistry and Materials Science
Chemistry/Food Science
Full
Full Articles
Inorganic Chemistry
Molecular docking
Organic Chemistry
Protease
Pyrazole
Severe acute respiratory syndrome coronavirus 2
Viruses
title Synthesis of non-symmetric N-benzylbispidinol amides and study of their inhibitory activity against the main protease of the SARS-CoV-2 virus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T09%3A57%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%20non-symmetric%20N-benzylbispidinol%20amides%20and%20study%20of%20their%20inhibitory%20activity%20against%20the%20main%20protease%20of%20the%20SARS-CoV-2%20virus&rft.jtitle=Russian%20chemical%20bulletin&rft.au=Dalinger,%20A.%20I.&rft.date=2023&rft.volume=72&rft.issue=1&rft.spage=239&rft.epage=247&rft.pages=239-247&rft.issn=1066-5285&rft.eissn=1573-9171&rft_id=info:doi/10.1007/s11172-023-3729-x&rft_dat=%3Cproquest_pubme%3E2779344746%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2776659674&rft_id=info:pmid/36817558&rfr_iscdi=true